Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.


Christen Mowad, MD
Section Editor
Joseph Fowler, MD
Deputy Editor
Rosamaria Corona, MD, DSc


Cheilitis is an acute or chronic inflammation of the lips. It usually involves the lip vermilion and the vermilion border, but the surrounding skin and the oral mucosa may also be affected [1]. Common symptoms include erythema dryness, scaling, fissuring, edema, itching, and burning.

Cheilitis may be caused by a multiplicity of endogenous or exogenous factors, the most common of which are atopic dermatitis, contact irritants or allergens, chronic sun exposure, and infection. Secondary involvement of the lips can occur in many cutaneous and systemic disorders, such as lichen planus, lupus erythematosus, autoimmune bullous diseases, Crohn disease, sarcoidosis, and nutritional deficiencies.

This topic will review the clinical manifestation, diagnosis, and treatment of primary lip diseases. The oral manifestations of cutaneous and systemic diseases are discussed separately.

(See "Oral lichen planus: Pathogenesis, clinical features, and diagnosis".)

(See "Overview of cutaneous lupus erythematosus".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Oct 2017. | This topic last updated: Sep 20, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Rogers RS 3rd, Bekic M. Diseases of the lips. Semin Cutan Med Surg 1997; 16:328.
  2. Lim SW, Goh CL. Epidemiology of eczematous cheilitis at a tertiary dermatological referral centre in Singapore. Contact Dermatitis 2000; 43:322.
  3. Zug KA, Kornik R, Belsito DV, et al. Patch-testing North American lip dermatitis patients: data from the North American Contact Dermatitis Group, 2001 to 2004. Dermatitis 2008; 19:202.
  4. Zoli V, Silvani S, Vincenzi C, Tosti A. Allergic contact cheilitis. Contact Dermatitis 2006; 54:296.
  5. Rademaker M. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin. Australas J Dermatol 2010; 51:248.
  6. Ornelas J, Rosamilia L, Larsen L, et al. Objective assessment of isotretinoin-associated cheilitis: Isotretinoin Cheilitis Grading Scale. J Dermatolog Treat 2016; 27:153.
  7. Freeman S, Stephens R. Cheilitis: analysis of 75 cases referred to a contact dermatitis clinic. Am J Contact Dermat 1999; 10:198.
  8. Strauss RM, Orton DI. Allergic contact cheilitis in the United Kingdom: a retrospective study. Am J Contact Dermat 2003; 14:75.
  9. Ophaswongse S, Maibach HI. Allergic contact cheilitis. Contact Dermatitis 1995; 33:365.
  10. Francalanci S, Sertoli A, Giorgini S, et al. Multicentre study of allergic contact cheilitis from toothpastes. Contact Dermatitis 2000; 43:216.
  11. Schena D, Fantuzzi F, Girolomoni G. Contact allergy in chronic eczematous lip dermatitis. Eur J Dermatol 2008; 18:688.
  12. Pascoe D, Moreau L, Sasseville D. Emergent and unusual allergens in cosmetics. Dermatitis 2010; 21:127.
  13. Aerts O, Leysen J, Horst N, et al. Contact dermatitis caused by pharmaceutical ointments containing 'ozonated' olive oil. Contact Dermatitis 2016; 75:123.
  14. Nyman G, Hagvall L. A case of allergic contact cheilitis caused by propolis and honey. Contact Dermatitis 2016; 74:186.
  15. Milanesi N, Gola M, Verdelli A, Francalanci S. Aspects of contact cheilitis: analysis of 38 cases. J Eur Acad Dermatol Venereol 2016; 30:1052.
  16. Savage NW, McKay C, Faulkner C. Actinic cheilitis in dental practice. Aust Dent J 2010; 55 Suppl 1:78.
  17. Cavalcante AS, Anbinder AL, Carvalho YR. Actinic cheilitis: clinical and histological features. J Oral Maxillofac Surg 2008; 66:498.
  18. Jadotte YT, Schwartz RA. Solar cheilosis: an ominous precursor: part I. Diagnostic insights. J Am Acad Dermatol 2012; 66:173.
  19. de Souza Lucena EE, Costa DC, da Silveira EJ, Lima KC. Prevalence and factors associated to actinic cheilitis in beach workers. Oral Dis 2012; 18:575.
  20. Miranda AM, Soares LG, Ferrari TM, et al. Prevalence of actinic cheilitis in a population of agricultural sugarcane workers. Acta Odontol Latinoam 2012; 25:201.
  21. Martins-Filho PR, Da Silva LC, Piva MR. The prevalence of actinic cheilitis in farmers in a semi-arid northeastern region of Brazil. Int J Dermatol 2011; 50:1109.
  22. de Santana Sarmento DJ, da Costa Miguel MC, Queiroz LM, et al. Actinic cheilitis: clinicopathologic profile and association with degree of dysplasia. Int J Dermatol 2014; 53:466.
  23. Zaiac M, Clement A. Treatment of actinic cheilitis by photodynamic therapy with 5-aminolevulinic acid and blue light activation. J Drugs Dermatol 2011; 10:1240.
  24. Jadotte YT, Schwartz RA. Solar cheilosis: an ominous precursor part II. Therapeutic perspectives. J Am Acad Dermatol 2012; 66:187.
  25. Kaugars GE, Pillion T, Svirsky JA, et al. Actinic cheilitis: a review of 152 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88:181.
  26. Vieira RA, Minicucci EM, Marques ME, Marques SA. Actinic cheilitis and squamous cell carcinoma of the lip: clinical, histopathological and immunogenetic aspects. An Bras Dermatol 2012; 87:105.
  27. Menta Simonsen Nico M, Rivitti EA, Lourenço SV. Actinic cheilitis: histologic study of the entire vermilion and comparison with previous biopsy. J Cutan Pathol 2007; 34:309.
  28. Sotiriou E, Lallas A, Goussi C, et al. Sequential use of photodynamic therapy and imiquimod 5% cream for the treatment of actinic cheilitis: a 12-month follow-up study. Br J Dermatol 2011; 165:888.
  29. Armenores P, James CL, Walker PC, Huilgol SC. Treatment of actinic cheilitis with the Er:YAG laser. J Am Acad Dermatol 2010; 63:642.
  30. Fai D, Romano I, Cassano N, Vena GA. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic cheilitis: a retrospective evaluation of 29 patients. G Ital Dermatol Venereol 2012; 147:99.
  31. Ishida CE, Ramos-e-Silva M. Cryosurgery in oral lesions. Int J Dermatol 1998; 37:283.
  32. Shah AY, Doherty SD, Rosen T. Actinic cheilitis: a treatment review. Int J Dermatol 2010; 49:1225.
  33. Sotiriou E, Apalla Z, Chovarda E, et al. Photodynamic therapy with 5-aminolevulinic acid in actinic cheilitis: an 18-month clinical and histological follow-up. J Eur Acad Dermatol Venereol 2010; 24:916.
  34. Gupta AK, Paquet M, Villanueva E, Brintnell W. Interventions for actinic keratoses. Cochrane Database Syst Rev 2012; 12:CD004415.
  35. Robinson JK. Actinic cheilitis. A prospective study comparing four treatment methods. Arch Otolaryngol Head Neck Surg 1989; 115:848.
  36. Smith KJ, Germain M, Yeager J, Skelton H. Topical 5% imiquimod for the therapy of actinic cheilitis. J Am Acad Dermatol 2002; 47:497.
  37. Barrado Solís N, Molés Poveda P, Lloret Ruiz C, et al. Ingenol mebutate gel treatment for actinic cheilitis: report of four cases. Dermatol Ther 2015; 28:79.
  38. Ulrich C, Forschner T, Ulrich M, et al. Management of actinic cheilitis using diclofenac 3% gel: a report of six cases. Br J Dermatol 2007; 156 Suppl 3:43.
  39. Lima Gda S, Silva GF, Gomes AP, et al. Diclofenac in hyaluronic acid gel: an alternative treatment for actinic cheilitis. J Appl Oral Sci 2010; 18:533.
  40. Castiñeiras I, Del Pozo J, Mazaira M, et al. Actinic cheilitis: evolution to squamous cell carcinoma after carbon dioxide laser vaporization. A study of 43 cases. J Dermatolog Treat 2010; 21:49.
  41. Yazdani Abyaneh MA, Falto-Aizpurua L, Griffith RD, Nouri K. Photodynamic therapy for actinic cheilitis: a systematic review. Dermatol Surg 2015; 41:189.
  42. Sand M, Altmeyer P, Bechara FG. Mucosal advancement flap versus primary closure after vermilionectomy of the lower lip. Dermatol Surg 2010; 36:1987.
  43. Barry RB, McKenzie J, Berg D, Langtry JA. Direct primary closure without undermining in the repair of vermilionectomy defects of the lower lip. Br J Dermatol 2012; 167:1092.
  44. Park KK, Brodell RT, Helms SE. Angular cheilitis, part 1: local etiologies. Cutis 2011; 87:289.
  45. Park KK, Brodell RT, Helms SE. Angular cheilitis, part 2: nutritional, systemic, and drug-related causes and treatment. Cutis 2011; 88:27.
  46. Terai H, Shimahara M. Cheilitis as a variation of Candida-associated lesions. Oral Dis 2006; 12:349.
  47. Cross DL, Short LJ. Angular cheilitis occurring during orthodontic treatment: a case series. J Orthod 2008; 35:229.
  48. Freitas JB, Gomez RS, De Abreu MH, Ferreira E Ferreira E. Relationship between the use of full dentures and mucosal alterations among elderly Brazilians. J Oral Rehabil 2008; 35:370.
  49. Sharon V, Fazel N. Oral candidiasis and angular cheilitis. Dermatol Ther 2010; 23:230.
  50. Al-Maweri SA, Ismail NM, Ismail AR, Al-Ghashm A. Prevalence of oral mucosal lesions in patients with type 2 diabetes attending hospital universiti sains malaysia. Malays J Med Sci 2013; 20:39.
  51. Ohman SC, Jontell M, Dahlen G. Recurrence of angular cheilitis. Scand J Dent Res 1988; 96:360.
  52. Farrier JN, Perkins CS. Plasma cell cheilitis. Br J Oral Maxillofac Surg 2008; 46:679.
  53. Choi JW, Choi M, Cho KH. Successful treatment of plasma cell cheilitis with topical calcineurin inhibitors. J Dermatol 2009; 36:669.
  54. Hanami Y, Motoki Y, Yamamoto T. Successful treatment of plasma cell cheilitis with topical tacrolimus: report of two cases. Dermatol Online J 2011; 17:6.
  55. Yang JH, Lee UH, Jang SJ, Choi JC. Plasma cell cheilitis treated with intralesional injection of corticosteroids. J Dermatol 2005; 32:987.
  56. White JW Jr, Olsen KD, Banks PM. Plasma cell orificial mucositis. Report of a case and review of the literature. Arch Dermatol 1986; 122:1321.
  57. Román CC, Yuste CM, González MA, et al. Plasma cell gingivitis. Cutis 2002; 69:41.
  58. Bharti R, Smith DR. Mucous membrane plasmacytosis: a case report and review of the literature. Dermatol Online J 2003; 9:15.
  59. Tamaki K, Osada A, Tsukamoto K, et al. Treatment of plasma cell cheilitis with griseofulvin. J Am Acad Dermatol 1994; 30:789.
  60. Tseng JT, Cheng CJ, Lee WR, Wang KH. Plasma-cell cheilitis: successful treatment with intralesional injections of corticosteroids. Clin Exp Dermatol 2009; 34:174.
  61. Jones SK, Kennedy CT. Response of plasma cell orificial mucositis to topically applied steroids. Arch Dermatol 1988; 124:1871.
  62. Heinemann C, Fischer T, Barta U, et al. Plasma cell mucositis with oral and genital involvement - successful treatment with topical cyclosporin. J Eur Acad Dermatol Venereol 2006; 20:739.
  63. Saruya K, Fukuda H, Saito R, et al. Plasmocytosis circumorificialis successfully treated with topical fusidic acid ointment. J Dermatol 2009; 36:232.
  64. Yoshimura K, Nakano S, Tsuruta D, et al. Successful treatment with 308-nm monochromatic excimer light and subsequent tacrolimus 0.03% ointment in refractory plasma cell cheilitis. J Dermatol 2013; 40:471.
  65. Carrington PR, Horn TD. Cheilitis glandularis: a clinical marker for both malignancy and/or severe inflammatory disease of the oral cavity. J Am Acad Dermatol 2006; 54:336.
  66. Stoopler ET, Carrasco L, Stanton DC, et al. Cheilitis glandularis: an unusual histopathologic presentation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95:312.
  67. Andrade ES, Sobral AP, Laureano Filho JR, et al. Cheilitis glandularis and actinic cheilitis: differential diagnoses - report of three unusual cases. Dermatol Online J 2009; 15:5.
  68. Bovenschen HJ. Novel treatment for cheilitis glandularis. Acta Derm Venereol 2009; 89:99.
  69. Nico MM, Nakano de Melo J, Lourenço SV. Cheilitis glandularis: a clinicopathological study in 22 patients. J Am Acad Dermatol 2010; 62:233.
  70. Reiter S, Vered M, Yarom N, et al. Cheilitis glandularis: clinico-histopathological diagnostic criteria. Oral Dis 2011; 17:335.
  71. Swerlick RA, Cooper PH. Cheilitis glandularis: a re-evaluation. J Am Acad Dermatol 1984; 10:466.
  72. Bender MM, Rubenstein M, Rosen T. Cheilitis glandularis in an African-American woman: response to antibiotic therapy. Skinmed 2005; 4:391.
  73. Critchlow WA, Chang D. Cheilitis granulomatosa: a review. Head Neck Pathol 2014; 8:209.
  74. McCartan BE, Healy CM, McCreary CE, et al. Characteristics of patients with orofacial granulomatosis. Oral Dis 2011; 17:696.
  75. Al Johani KA, Moles DR, Hodgson TA, et al. Orofacial granulomatosis: clinical features and long-term outcome of therapy. J Am Acad Dermatol 2010; 62:611.
  76. Miest R, Bruce A, Rogers RS 3rd. Orofacial granulomatosis. Clin Dermatol 2016; 34:505.
  77. Balevi B. Melkersson-Rosenthal syndrome: review of the literature and case report of a 10-year misdiagnosis. Quintessence Int 1997; 28:265.
  78. Howell JL, Bussell RM, Hegarty AM, Zaitoun H. Service evaluation of patients with orofacial granulomatosis and patients with oral Crohn's disease attending a paediatric oral medicine clinic. Eur Arch Paediatr Dent 2012; 13:191.
  79. van der Waal RI, Schulten EA, van de Scheur MR, et al. Cheilitis granulomatosa. J Eur Acad Dermatol Venereol 2001; 15:519.
  80. Elias MK, Mateen FJ, Weiler CR. The Melkersson-Rosenthal syndrome: a retrospective study of biopsied cases. J Neurol 2013; 260:138.
  81. KO CJ, Glusac EJ, Shapiro PE. Noninfectious granulomas. In: Lever's Histopathology of the Skin, 10th ed, Elder D, Elenitsas R, Johnson BL, et al (Eds), Wolters Kluwer-Lippincott Williams & Wilkins, Philadelphia 2009. p.361.
  82. Dupuy A, Cosnes J, Revuz J, et al. Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases. Arch Dermatol 1999; 135:439.
  83. Girlich C, Bogenrieder T, Palitzsch KD, et al. Orofacial granulomatosis as initial manifestation of Crohn's disease: a report of two cases. Eur J Gastroenterol Hepatol 2002; 14:873.
  84. Eversole R, Tran K, Hansen D, Campbell J. Lip augmentation dermal filler reactions, histopathologic features. Head Neck Pathol 2013; 7:241.
  85. Kiliç A, Gül U, Gönül M, et al. Orificial tuberculosis of the lip: a case report and review of the literature. Int J Dermatol 2009; 48:178.
  86. Ramesh V. Orofacial Granulomatosis due to Tuberculosis. Pediatr Dermatol 2009; 26:108.
  87. Kavala M, Südoğan S, Can B, Sarigül S. Granulomatous cheilitis resulting from a tuberculide. Int J Dermatol 2004; 43:524.
  88. Serarslan G, Aksakal M. Cutaneous leishmaniasis mimicking granulomatous cheilitis and treated successfully with oral fluconazole in a boy. Ann Parasitol 2015; 61:197.
  89. Banks T, Gada S. A comprehensive review of current treatments for granulomatous cheilitis. Br J Dermatol 2012; 166:934.
  90. Bacci C, Valente ML. Successful treatment of cheilitis granulomatosa with intralesional injection of triamcinolone. J Eur Acad Dermatol Venereol 2010; 24:363.
  91. Lynde CB, Bruce AJ, Orvidas LJ, et al. Cheilitis granulomatosa treated with intralesional corticosteroids and anti-inflammatory agents. J Am Acad Dermatol 2011; 65:e101.
  92. El-Hakim M, Chauvin P. Orofacial granulomatosis presenting as persistent lip swelling: review of 6 new cases. J Oral Maxillofac Surg 2004; 62:1114.
  93. Fedele S, Fung PP, Bamashmous N, et al. Long-term effectiveness of intralesional triamcinolone acetonide therapy in orofacial granulomatosis: an observational cohort study. Br J Dermatol 2014; 170:794.
  94. Mignogna MD, Fedele S, Lo Russo L, et al. Effectiveness of small-volume, intralesional, delayed-release triamcinolone injections in orofacial granulomatosis: a pilot study. J Am Acad Dermatol 2004; 51:265.
  95. Veller Fornasa C, Catalano P, Peserico A. Minocycline in granulomatous cheilitis: experience with 6 cases. Dermatology 1992; 185:220.
  96. Ishiguro E, Hatamochi A, Hamasaki Y, et al. Successful treatment of granulomatous cheilitis with roxithromycin. J Dermatol 2008; 35:598.
  97. Coskun B, Saral Y, Cicek D, Akpolat N. Treatment and follow-up of persistent granulomatous cheilitis with intralesional steroid and metronidazole. J Dermatolog Treat 2004; 15:333.
  98. Fdez-Freire LR, Serrano Gotarredona A, Bernabeu Wittel J, et al. Clofazimine as elective treatment for granulomatous cheilitis. J Drugs Dermatol 2005; 4:374.
  99. Sobjanek M, Włodarkiewicz A, Zelazny I, et al. Successful treatment of Melkersson-Rosenthal syndrome with dapsone and triamcinolone injections. J Eur Acad Dermatol Venereol 2008; 22:1028.
  100. Medeiros M Jr, Araujo MI, Guimarães NS, et al. Therapeutic response to thalidomide in Melkersson-Rosenthal syndrome: a case report. Ann Allergy Asthma Immunol 2002; 88:421.
  101. Barry O, Barry J, Langan S, et al. Treatment of granulomatous cheilitis with infliximab. Arch Dermatol 2005; 141:1080.
  102. Ruiz Villaverde R, Sánchez Cano D. Successful treatment of granulomatous cheilitis with adalimumab. Int J Dermatol 2012; 51:118.
  103. Peitsch WK, Kemmler N, Goerdt S, Goebeler M. Infliximab: a novel treatment option for refractory orofacial granulomatosis. Acta Derm Venereol 2007; 87:265.
  104. Kruse-Lösler B, Presser D, Metze D, Joos U. Surgical treatment of persistent macrocheilia in patients with Melkersson-Rosenthal syndrome and cheilitis granulomatosa. Arch Dermatol 2005; 141:1085.